Evidence map›Paper›PMID 24167318›Full record

ArticleStem cells translational medicine2013

Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.

Rui-Zhe Phang, Felix Chang Tay, Sal-Lee Goh, Cia-Hin Lau, Haibao Zhu, Wee-Kiat Tan, Qingle Liang, Can Chen, Shouhui Du, Zhendong Li and 6 more

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Enhancing Cystic Fibrosis Immune Regulation.Frontiers in pharmacology · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Rui-Zhe PhangDepartment of Biological Sciences, National University of Singapore, Singapore.
Felix Chang Tay
Sal-Lee Goh
Cia-Hin Lau
Haibao Zhu
Wee-Kiat Tan
Qingle Liang
Can Chen
Shouhui Du
Zhendong Li
Johan Chin-Kang Tay
Chunxiao Wu
Jieming Zeng
Weimin Fan
Han Chong Toh
Shu Wang
National University of Singapore · SGInstitute of Bioengineering and Nanotechnology · SGFirst Affiliated Hospital Zhejiang University · CNNational Cancer Centre Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrative gene transfer using retroviruses to express reprogramming factors displays high efficiency in generating induced pluripotent stem cells (iPSCs), but the value of the method is limited because of the concern over mutagenesis associated with random insertion of transgenes. Site-specific integration into a preselected locus by engineered zinc-finger nuclease (ZFN) technology provides a potential way to overcome the problem. Here, we report the successful reprogramming of human fibroblasts into a state of pluripotency by baculoviral transduction-mediated, site-specific integration of OKSM (Oct3/4, Klf4, Sox2, and c-myc) transcription factor genes into the AAVS1 locus in human chromosome 19. Two nonintegrative baculoviral vectors were used for cotransduction, one expressing ZFNs and another as a donor vector encoding the four transcription factors. iPSC colonies were obtained at a high efficiency of 12% (the mean value of eight individual experiments). All characterized iPSC clones carried the transgenic cassette only at the ZFN-specified AAVS1 locus. We further demonstrated that when the donor cassette was flanked by heterospecific loxP sequences, the reprogramming genes in iPSCs could be replaced by another transgene using a baculoviral vector-based Cre recombinase-mediated cassette exchange system, thereby producing iPSCs free of exogenous reprogramming factors. Although the use of nonintegrating methods to generate iPSCs is rapidly becoming a standard approach, methods based on site-specific integration of reprogramming factor genes as reported here hold the potential for efficient generation of genetically amenable iPSCs suitable for future gene therapy applications.

Indexed as

Cellular ReprogrammingGenetic VectorsTransduction, GeneticZinc FingersBaculoviridaeCell DifferentiationCell LineChromosomes, Human, Pair 19EndonucleasesFibroblastsGene Expression Regulation, DevelopmentalGenotypeHumansInduced Pluripotent Stem CellsIntegrasesKruppel-Like Factor 4Cre recombinaseEndonucleasesIntegrasesKLF4 protein, humanKruppel-Like Factor 4Kruppel-Like Transcription FactorsMYC protein, humanOctamer Transcription Factor-3POU5F1 protein, humanProto-Oncogene Proteins c-mycSOX2 protein, humanSOXB1 Transcription FactorsTranscription FactorsCre-loxP systemGene delivery systems in vivo or in vitroGene expressionInduced pluripotent stem cells

Identifiers

PMID24167318
PMCPMC3841088
OpenAlexW2004412843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.